Purdue Sues Teva To Block 'Abuse-Proof' OxyContin Generic
Purdue Pharma LP hit Teva Pharmaceuticals USA Inc. with a suit in federal court in New York on Tuesday accusing Teva of patent infringement for seeking approval for a generic "abuse-proof"...To view the full article, register now.
Already a subscriber? Click here to view full article